Disposable Home Test for HbA1c

A test for measuring glycated hemoglobin (HbA1c, or A1C) that provides immediate results is designed for use by diabetes patients at home. The test has been cleared by the U.S. Food and Drug Administration (FDA).

Called ChoiceDM, the disposable device allows at-home diabetes patients to track their progress and help their healthcare professionals in monitoring response to treatment. The three-step test provides results in eight minutes from a small drop of blood. The test will be sold in pharmacies without a prescription. It is the product of Bristol-Myers Squibb Company (New York, NY, USA).

A1C is the preferred standard indicator for measuring long-term blood sugar control. The American Diabetes Association recommends A1C testing on all patients with diabetes up to four times a year. Patients who are modifying their diet or exercise regimen may measure their A1C levels to track their progress. Studies have shown that a 1% reduction in A1C decreases the risk of serious complications in diabetics, such as eye, kidney, and nerve damage. The ADA recommends that diabetics maintain an A1C level of 7% or less.

"Not only is it more convenient, but it will also motivate patients to be more informed and active participants in their own diabetes management,” commented Dr. Steve Edelman, professor of medicine at the University of California, San Diego (USA). "There is no question that the widespread availability of the ChoiceDM A1C home test will improve diabetes care over the short and long term.”




Related Links:
Bristol-Myers Squibb